This patient was diagnosed with nAMD at 3.6 years after vitrectomy for rhegmatogenous retinal detachment and had a successful initial response to anti-VEGF; the CFT was 237 μm (53.7% of baseline). This evidence concerns the gene VEGFA and rhegmatogenous retinal detachment.